31749684|t|Decrease of GSK-3beta Activity in the Anterior Cingulate Cortex of Shank3b -/- Mice Contributes to Synaptic and Social Deficiency.
31749684|a|Social deficiency is one of the core syndromes of autism spectrum disorders (ASD), for which the underlying developmental mechanism still remains elusive. Anterior cingulate cortex (ACC) plays a key role in integrating social information and regulating social behavior. Recent studies have indicated that synaptic dysfunction in ACC is essential for ASD social defects. In the present study, we investigated the development of synapses and the roles of glycogen synthase kinase 3beta (GSK-3beta), which mediates multiple synaptic signaling pathways in ACC by using Shank3b -/- mice (a widely used ASD mouse model). Our data revealed that Shank3b mutation abolished the social induced c-Fos expression in ACC. From 4 weeks post-birth, neurons in Shank3b -/- ACC exhibited an obvious decrease in spine density and stubby spines. The length and thickness of post-synaptic density (PSD), the expression of vesicular glutamate transporter 2 (vGlut2) and glutamate receptor 2 (GluR2), and the frequency of miniature excitatory post-synaptic currents (mEPSCs) were significantly reduced in Shank3b -/-ACC. Interestingly, the levels of phosphorylated GSK-3beta (Ser9), which inhibits the activity of GSK-3beta, decreased along the same time course as the levels of GluR2 increased in ACC during development. Shank3b mutation leads to a dramatic increase of pGSK-3beta (Ser9), and decrease of pPSD95 (a substrate of GSK-3beta) and GluR2. Local delivery of AAV expressing constitutively active GSK-3beta restored the expression of GluR2, increased the spine density and the number of mature spines. More importantly, active GSK-3beta significantly promoted the social activity of Shank3b -/- mice. These data, in together, indicate that decrease of GSK-3beta activity in ACC may contribute to the synaptic and social defects of Shank3b -/- mice. Enhancing GSK-3beta activity may be utilized to treat ASD in the future.
31749684	12	21	GSK-3beta	Gene	56637
31749684	67	74	Shank3b	Gene	58234
31749684	79	83	Mice	Species	10090
31749684	99	129	Synaptic and Social Deficiency	Disease	MESH:D012183
31749684	131	148	Social deficiency	Disease	MESH:D000067404
31749684	181	206	autism spectrum disorders	Disease	MESH:D000067877
31749684	208	211	ASD	Disease	MESH:D000067877
31749684	481	499	ASD social defects	Disease	MESH:D000067877
31749684	584	614	glycogen synthase kinase 3beta	Gene	56637
31749684	616	625	GSK-3beta	Gene	56637
31749684	696	703	Shank3b	Gene	58234
31749684	708	712	mice	Species	10090
31749684	728	731	ASD	Disease	MESH:D000067877
31749684	732	737	mouse	Species	10090
31749684	769	776	Shank3b	Gene	58234
31749684	815	820	c-Fos	Gene	14281
31749684	876	883	Shank3b	Gene	58234
31749684	1033	1066	vesicular glutamate transporter 2	Gene	140919
31749684	1068	1074	vGlut2	Gene	140919
31749684	1080	1100	glutamate receptor 2	Gene	14800
31749684	1102	1107	GluR2	Gene	14800
31749684	1214	1221	Shank3b	Gene	58234
31749684	1274	1283	GSK-3beta	Gene	56637
31749684	1323	1332	GSK-3beta	Gene	56637
31749684	1388	1393	GluR2	Gene	14800
31749684	1431	1438	Shank3b	Gene	58234
31749684	1538	1547	GSK-3beta	Gene	56637
31749684	1553	1558	GluR2	Gene	14800
31749684	1615	1624	GSK-3beta	Gene	56637
31749684	1652	1657	GluR2	Gene	14800
31749684	1745	1754	GSK-3beta	Gene	56637
31749684	1801	1808	Shank3b	Gene	58234
31749684	1813	1817	mice	Species	10090
31749684	1870	1879	GSK-3beta	Gene	56637
31749684	1949	1956	Shank3b	Gene	58234
31749684	1961	1965	mice	Species	10090
31749684	1977	1986	GSK-3beta	Gene	56637
31749684	2021	2024	ASD	Disease	MESH:D000067877
31749684	Positive_Correlation	14281	58234
31749684	Positive_Correlation	14800	56637
31749684	Association	MESH:D012183	58234
31749684	Association	MESH:D012183	56637
31749684	Association	140919	58234
31749684	Negative_Correlation	MESH:D000067877	56637
31749684	Negative_Correlation	140919	56637
31749684	Negative_Correlation	14800	58234
31749684	Association	56637	58234

